FDA Approves Rezzayo (rezafungin for injection) for the Treatment of Candidemia and Invasive Candidiasis

SAN DIEGO& PARSIPPANY, N.J.--(BUSINESS WIRE)-- March 22, 2023 -- Cidara Therapeutics, Inc. (Nasdaq: CDTX) and Melinta Therapeutics, LLC today announced that the U.S. Food and Drug Administration (FDA) approved Rezzayo (rezafungin for injection)...
Source: Drugs.com - New Drug Approvals - Category: Drugs & Pharmacology Source Type: news